RNA Sequencing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510244537

Publication Date:

October 25, 2024

Pages:

131

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

RNA sequencing (RNA-seq) captures a broad range of gene expression changes and enables the detection of novel transcripts in both coding and non-coding RNA species.
The global market for RNA Sequencing Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for RNA Sequencing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Sequencing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for RNA Sequencing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of RNA Sequencing Services include Thermo Fisher, BGI, Illumina, Active Motif, CD Genomics, Exiqon, Novogene, GENEWIZ and LC Sciences, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Sequencing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNA Sequencing Services by region & country, by Type, and by Application.
The RNA Sequencing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Sequencing Services.
Market Segmentation
By Company
Thermo Fisher
BGI
Illumina
Active Motif
CD Genomics
Exiqon
Novogene
GENEWIZ
LC Sciences
Diagenode
Arraystar
BaseClear
Phalanx Biotech
CeGaT GmbH
Genomax
Qiagen
Segment by Type:
Ribosomal RNA (rRNA)
Transfer RNA (tRNA)
Long ncRNA (lncRNA)
Segment by Application
Academic & Government Institutes and Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNA Sequencing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNA Sequencing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNA Sequencing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 RNA Sequencing Services Product Introduction
1.2 Global RNA Sequencing Services Market Size Forecast
1.3 RNA Sequencing Services Market Trends & Drivers
1.3.1 RNA Sequencing Services Industry Trends
1.3.2 RNA Sequencing Services Market Drivers & Opportunity
1.3.3 RNA Sequencing Services Market Challenges
1.3.4 RNA Sequencing Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global RNA Sequencing Services Players Revenue Ranking (2023)
2.2 Global RNA Sequencing Services Revenue by Company (2019-2024)
2.3 Key Companies RNA Sequencing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies RNA Sequencing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of RNA Sequencing Services
2.6 RNA Sequencing Services Market Competitive Analysis
2.6.1 RNA Sequencing Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by RNA Sequencing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Sequencing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ribosomal RNA (rRNA)
3.1.2 Transfer RNA (tRNA)
3.1.3 Long ncRNA (lncRNA)
3.2 Global RNA Sequencing Services Sales Value by Type
3.2.1 Global RNA Sequencing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global RNA Sequencing Services Sales Value, by Type (2019-2030)
3.2.3 Global RNA Sequencing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic & Government Institutes and Research Centers
4.1.2 Hospitals & Clinics
4.1.3 Pharmaceutical & Biotechnology Companies
4.1.4 Other End Users
4.2 Global RNA Sequencing Services Sales Value by Application
4.2.1 Global RNA Sequencing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global RNA Sequencing Services Sales Value, by Application (2019-2030)
4.2.3 Global RNA Sequencing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global RNA Sequencing Services Sales Value by Region
5.1.1 Global RNA Sequencing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global RNA Sequencing Services Sales Value by Region (2019-2024)
5.1.3 Global RNA Sequencing Services Sales Value by Region (2025-2030)
5.1.4 Global RNA Sequencing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America RNA Sequencing Services Sales Value, 2019-2030
5.2.2 North America RNA Sequencing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe RNA Sequencing Services Sales Value, 2019-2030
5.3.2 Europe RNA Sequencing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific RNA Sequencing Services Sales Value, 2019-2030
5.4.2 Asia Pacific RNA Sequencing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America RNA Sequencing Services Sales Value, 2019-2030
5.5.2 South America RNA Sequencing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa RNA Sequencing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa RNA Sequencing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions RNA Sequencing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions RNA Sequencing Services Sales Value
6.3 United States
6.3.1 United States RNA Sequencing Services Sales Value, 2019-2030
6.3.2 United States RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe RNA Sequencing Services Sales Value, 2019-2030
6.4.2 Europe RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China RNA Sequencing Services Sales Value, 2019-2030
6.5.2 China RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan RNA Sequencing Services Sales Value, 2019-2030
6.6.2 Japan RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea RNA Sequencing Services Sales Value, 2019-2030
6.7.2 South Korea RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia RNA Sequencing Services Sales Value, 2019-2030
6.8.2 Southeast Asia RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia RNA Sequencing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India RNA Sequencing Services Sales Value, 2019-2030
6.9.2 India RNA Sequencing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India RNA Sequencing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Profile
7.1.2 Thermo Fisher Main Business
7.1.3 Thermo Fisher RNA Sequencing Services Products, Services and Solutions
7.1.4 Thermo Fisher RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Recent Developments
7.2 BGI
7.2.1 BGI Profile
7.2.2 BGI Main Business
7.2.3 BGI RNA Sequencing Services Products, Services and Solutions
7.2.4 BGI RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.2.5 BGI Recent Developments
7.3 Illumina
7.3.1 Illumina Profile
7.3.2 Illumina Main Business
7.3.3 Illumina RNA Sequencing Services Products, Services and Solutions
7.3.4 Illumina RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Active Motif Recent Developments
7.4 Active Motif
7.4.1 Active Motif Profile
7.4.2 Active Motif Main Business
7.4.3 Active Motif RNA Sequencing Services Products, Services and Solutions
7.4.4 Active Motif RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Active Motif Recent Developments
7.5 CD Genomics
7.5.1 CD Genomics Profile
7.5.2 CD Genomics Main Business
7.5.3 CD Genomics RNA Sequencing Services Products, Services and Solutions
7.5.4 CD Genomics RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.5.5 CD Genomics Recent Developments
7.6 Exiqon
7.6.1 Exiqon Profile
7.6.2 Exiqon Main Business
7.6.3 Exiqon RNA Sequencing Services Products, Services and Solutions
7.6.4 Exiqon RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.6.5 Exiqon Recent Developments
7.7 Novogene
7.7.1 Novogene Profile
7.7.2 Novogene Main Business
7.7.3 Novogene RNA Sequencing Services Products, Services and Solutions
7.7.4 Novogene RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.7.5 Novogene Recent Developments
7.8 GENEWIZ
7.8.1 GENEWIZ Profile
7.8.2 GENEWIZ Main Business
7.8.3 GENEWIZ RNA Sequencing Services Products, Services and Solutions
7.8.4 GENEWIZ RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.8.5 GENEWIZ Recent Developments
7.9 LC Sciences
7.9.1 LC Sciences Profile
7.9.2 LC Sciences Main Business
7.9.3 LC Sciences RNA Sequencing Services Products, Services and Solutions
7.9.4 LC Sciences RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.9.5 LC Sciences Recent Developments
7.10 Diagenode
7.10.1 Diagenode Profile
7.10.2 Diagenode Main Business
7.10.3 Diagenode RNA Sequencing Services Products, Services and Solutions
7.10.4 Diagenode RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.10.5 Diagenode Recent Developments
7.11 Arraystar
7.11.1 Arraystar Profile
7.11.2 Arraystar Main Business
7.11.3 Arraystar RNA Sequencing Services Products, Services and Solutions
7.11.4 Arraystar RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.11.5 Arraystar Recent Developments
7.12 BaseClear
7.12.1 BaseClear Profile
7.12.2 BaseClear Main Business
7.12.3 BaseClear RNA Sequencing Services Products, Services and Solutions
7.12.4 BaseClear RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.12.5 BaseClear Recent Developments
7.13 Phalanx Biotech
7.13.1 Phalanx Biotech Profile
7.13.2 Phalanx Biotech Main Business
7.13.3 Phalanx Biotech RNA Sequencing Services Products, Services and Solutions
7.13.4 Phalanx Biotech RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.13.5 Phalanx Biotech Recent Developments
7.14 CeGaT GmbH
7.14.1 CeGaT GmbH Profile
7.14.2 CeGaT GmbH Main Business
7.14.3 CeGaT GmbH RNA Sequencing Services Products, Services and Solutions
7.14.4 CeGaT GmbH RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.14.5 CeGaT GmbH Recent Developments
7.15 Genomax
7.15.1 Genomax Profile
7.15.2 Genomax Main Business
7.15.3 Genomax RNA Sequencing Services Products, Services and Solutions
7.15.4 Genomax RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.15.5 Genomax Recent Developments
7.16 Qiagen
7.16.1 Qiagen Profile
7.16.2 Qiagen Main Business
7.16.3 Qiagen RNA Sequencing Services Products, Services and Solutions
7.16.4 Qiagen RNA Sequencing Services Revenue (US$ Million) & (2019-2024)
7.16.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 RNA Sequencing Services Industrial Chain
8.2 RNA Sequencing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 RNA Sequencing Services Sales Model
8.5.2 Sales Channel
8.5.3 RNA Sequencing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher
BGI
Illumina
Active Motif
CD Genomics
Exiqon
Novogene
GENEWIZ
LC Sciences
Diagenode
Arraystar
BaseClear
Phalanx Biotech
CeGaT GmbH
Genomax
Qiagen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂